Avadomide (CC-122)

Avadomide (CC-122), a new chemical entity termed pleiotropic pathway modifier, is a novel agent for Diffuse large B-cell lymphoma(DLBCL) with antitumor and immunomodulatory activity. Its molecular target is the protein cereblon (CRBN), a substrate receptor of the cullin ring E3 ubiquitin ligase complex CRL4CRBN.

Price Not Available 2mg Avadomide (CC-122) Supplier Page
Trivial name N/A
Catalog Number S7892
CAS# 1015474-32-4
Size 2mg
Supplier Page http://www.selleckchem.com/products/cc-122.html
Additional Information https://file.selleck.cn/downloads/struct/cc-122-chemical-structure-s7892.gif